The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic Adenocarcinoma
Official Title: Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic Adenocarcinoma
Study ID: NCT02876991
Brief Summary: The purpose is to evaluate if sodium fluoride PET in patients having already undergone a choline PET negative for bone extension (non-metastatic status) modifies the status of patients concerning the existence or not of bone metastases. Secondary purposes are: * To evaluate if detection of bone metastasis by sodium fluoride PET, not detected by choline PET, leads to change of treatment * To evaluate inter-technique concordance (choline vs sodium fluoride PET) of results (metastatic status and number of lesions) * To evaluate the inter-judge concordance of interpretation of sodium fluoride PET * To study the discordance of metastatic status of 2 techniques.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Service de Médecine Nucléaire CHRU de Nancy-Brabois, Vandœuvre-lès-Nancy, , France
Name: Pierre OLIVIER, Pr
Affiliation: Service de Médecine Nucléaire - CHRU de Nancy-Brabois - Vandœuvre-lès-Nancy
Role: PRINCIPAL_INVESTIGATOR